These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1211 related articles for article (PubMed ID: 14559814)

  • 1. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.
    Ma PC; Kijima T; Maulik G; Fox EA; Sattler M; Griffin JD; Johnson BE; Salgia R
    Cancer Res; 2003 Oct; 63(19):6272-81. PubMed ID: 14559814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer.
    Maulik G; Kijima T; Ma PC; Ghosh SK; Lin J; Shapiro GI; Schaefer E; Tibaldi E; Johnson BE; Salgia R
    Clin Cancer Res; 2002 Feb; 8(2):620-7. PubMed ID: 11839685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the focal adhesion protein paxillin in lung cancer and its relation to cell motility.
    Salgia R; Li JL; Ewaniuk DS; Wang YB; Sattler M; Chen WC; Richards W; Pisick E; Shapiro GI; Rollins BJ; Chen LB; Griffin JD; Sugarbaker DJ
    Oncogene; 1999 Jan; 18(1):67-77. PubMed ID: 9926921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus-mediated siRNA targeting c-Met inhibits proliferation and invasion of small-cell lung cancer (SCLC) cells.
    Wang ZX; Lu BB; Yang JS; Wang KM; De W
    J Surg Res; 2011 Nov; 171(1):127-35. PubMed ID: 20338593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel germ line juxtamembrane Met mutation in human gastric cancer.
    Lee JH; Han SU; Cho H; Jennings B; Gerrard B; Dean M; Schmidt L; Zbar B; Vande Woude GF
    Oncogene; 2000 Oct; 19(43):4947-53. PubMed ID: 11042681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571.
    Wang WL; Healy ME; Sattler M; Verma S; Lin J; Maulik G; Stiles CD; Griffin JD; Johnson BE; Salgia R
    Oncogene; 2000 Jul; 19(31):3521-8. PubMed ID: 10918610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the decreased expression of alpha3beta1 integrin with the altered cell: environmental interactions and enhanced soft agar cloning ability of c-myc-overexpressing small cell lung cancer cells.
    Barr LF; Campbell SE; Bochner BS; Dang CV
    Cancer Res; 1998 Dec; 58(23):5537-45. PubMed ID: 9850091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imatinib mesylate efficiently achieves therapeutic intratumor concentrations in vivo but has limited activity in a xenograft model of small cell lung cancer.
    Wolff NC; Randle DE; Egorin MJ; Minna JD; Ilaria RL
    Clin Cancer Res; 2004 May; 10(10):3528-34. PubMed ID: 15161712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel somatic mutations of the MET oncogene in human carcinoma metastases activating cell motility and invasion.
    Lorenzato A; Olivero M; Patanè S; Rosso E; Oliaro A; Comoglio PM; Di Renzo MF
    Cancer Res; 2002 Dec; 62(23):7025-30. PubMed ID: 12460923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Met is a potentially new therapeutic target for treatment of human melanoma.
    Puri N; Ahmed S; Janamanchi V; Tretiakova M; Zumba O; Krausz T; Jagadeeswaran R; Salgia R
    Clin Cancer Res; 2007 Apr; 13(7):2246-53. PubMed ID: 17404109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human small cell lung cancer cells express functional VEGF receptors, VEGFR-2 and VEGFR-3.
    Tanno S; Ohsaki Y; Nakanishi K; Toyoshima E; Kikuchi K
    Lung Cancer; 2004 Oct; 46(1):11-9. PubMed ID: 15364128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer.
    Modi S; Kubo A; Oie H; Coxon AB; Rehmatulla A; Kaye FJ
    Oncogene; 2000 Sep; 19(40):4632-9. PubMed ID: 11030152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance.
    Boldrini L; Ursino S; Gisfredi S; Faviana P; Donati V; Camacci T; Lucchi M; Mussi A; Basolo F; Pingitore R; Fontanini G
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4101-8. PubMed ID: 15217946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of proliferation by L-myc antisense DNA for the translational initiation site in human small cell lung cancer.
    Dosaka-Akita H; Akie K; Hiroumi H; Kinoshita I; Kawakami Y; Murakami A
    Cancer Res; 1995 Apr; 55(7):1559-64. PubMed ID: 7882365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric cancer cell line Hs746T harbors a splice site mutation of c-Met causing juxtamembrane domain deletion.
    Asaoka Y; Tada M; Ikenoue T; Seto M; Imai M; Miyabayashi K; Yamamoto K; Yamamoto S; Kudo Y; Mohri D; Isomura Y; Ijichi H; Tateishi K; Kanai F; Ogawa S; Omata M; Koike K
    Biochem Biophys Res Commun; 2010 Apr; 394(4):1042-6. PubMed ID: 20331976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of p64c-myc and neuroendocrine properties define three subclasses of small cell lung cancer.
    Bepler G; Bading H; Heimann B; Kiefer P; Havemann K; Moelling K
    Oncogene; 1989 Jan; 4(1):45-50. PubMed ID: 2536917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autocrine growth of small cell lung cancer mediated by coexpression of c-kit and stem cell factor.
    Krystal GW; Hines SJ; Organ CP
    Cancer Res; 1996 Jan; 56(2):370-6. PubMed ID: 8542594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Myc suppresses the tumorigenicity of lung cancer cells and down-regulates vascular endothelial growth factor expression.
    Barr LF; Campbell SE; Diette GB; Gabrielson EW; Kim S; Shim H; Dang CV
    Cancer Res; 2000 Jan; 60(1):143-9. PubMed ID: 10646866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different roles for caveolin-1 in the development of non-small cell lung cancer versus small cell lung cancer.
    Sunaga N; Miyajima K; Suzuki M; Sato M; White MA; Ramirez RD; Shay JW; Gazdar AF; Minna JD
    Cancer Res; 2004 Jun; 64(12):4277-85. PubMed ID: 15205342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A selective small molecule inhibitor of c-Met, PHA665752, inhibits tumorigenicity and angiogenesis in mouse lung cancer xenografts.
    Puri N; Khramtsov A; Ahmed S; Nallasura V; Hetzel JT; Jagadeeswaran R; Karczmar G; Salgia R
    Cancer Res; 2007 Apr; 67(8):3529-34. PubMed ID: 17440059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.